Strategic Deal Making at Millennium Pharmaceuticals Harvard Case Solution & Analysis

A small launch in 1993, Millennium Pharmaceuticals was the name-brand biotechnology company by the end of 1998, with a market capitalization of $ 1.4 billion. Growth Strategy Cambridge based company relied mainly on alliances in the early stages of drugs and licensing its gene technology. "Hide
by Michael D. Watkins, Sarah G. Matthews Source: Harvard Business School 24 pages. Publication Date: September 27, 1999. Prod. #: 800032-PDF-ENG

Strategic Deal Making at Millennium Pharmaceuticals Case Solution Other Similar Case Solutions like

Strategic Deal Making at Millennium Pharmaceuticals

Share This